Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI2068

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

N Nagvekar, A M Moody, P Moss, I Roxanis, J Curnow, D Beeson, N Pantic, J Newsom-Davis, A Vincent, and N Willcox

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Nagvekar, N. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Moody, A. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Moss, P. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Roxanis, I. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Curnow, J. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Beeson, D. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Pantic, N. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Newsom-Davis, J. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Vincent, A. in: PubMed | Google Scholar

Neuroscience Group, Institute for Molecular Medicine, University of Oxford, OX3 9DS, United Kingdom.

Find articles by Willcox, N. in: PubMed | Google Scholar

Published May 15, 1998 - More info

Published in Volume 101, Issue 10 on May 15, 1998
J Clin Invest. 1998;101(10):2268–2277. https://doi.org/10.1172/JCI2068.
© 1998 The American Society for Clinical Investigation
Published May 15, 1998 - Version history
View PDF
Abstract

Myasthenia gravis (MG) is caused by helper T cell-dependent autoantibodies against the muscle acetylcholine receptor (AChR). Thymic epithelial tumors (thymomas) occur in 10% of MG patients, but their autoimmunizing potential is unclear. They express mRNAs encoding AChR alpha and epsilon subunits, and might aberrantly select or sensitize developing thymocytes or recirculating peripheral T cells against AChR epitopes. Alternatively, there could be defective self-tolerance induction in the abundant maturing thymocytes that they usually generate. For the first time, we have isolated and characterized AChR-specific T cell clones from two MG thymomas. They recognize extracellular epitopes (alpha75-90 and alpha149-158) which are processed very efficiently from muscle AChR. Both clones express CD4 and CD8alpha, and have a Th-0 cytokine profile, producing IL-4 as well as IFN-gamma. They are restricted to HLA-DP14 and DR52a; expression of these minority isotypes was strong on professional antigen-presenting cells in the donors' tumors, although it is generally weak in the periphery. The two clones' T cell receptor beta chains are different, but their alpha chain sequences are very similar. These resemblances, and the striking contrasts with T cells previously cloned from non-thymoma patients, show that thymomas generate and actively induce specific T cells rather than merely failing to tolerize them against self antigens.

Version history
  • Version 1 (May 15, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts